WaveMan · Form 4
Graham Richard A insider trades
> Search tickers & screens ⌘K
LIVE

Graham Richard A insider trades

Graham Richard A has filed 28 Form 4s with the SEC that we hold, all for Theravance Biopharma, Inc. (TBPH), as SVP, RESEARCH & DEVELOPMENT. Across all of them we count 0 purchases worth $0 and 13 sales worth $446.9K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 15,086 shares of Theravance Biopharma, Inc. worth $132.6K, dated 2022-08-09. The first filing on our record is dated 2021-08-24 and the latest 2024-02-22.

Theravance Biopharma, Inc. (TBPH)

SVP, RESEARCH & DEVELOPMENT · 28 filings · 13 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-08-09S, sale reported on Form 415,086$132.6K2022-08-11
2022-08-16S, sale reported on Form 44,906$47.6K2022-08-18
2022-12-01S, sale reported on Form 42,084$22.4K2022-12-05
2023-03-06S, sale reported on Form 42,323$23.3K2023-03-08
2023-03-14S, sale reported on Form 42,323$24.0K2023-03-16
2023-04-14S, sale reported on Form 42,323$27.6K2023-04-18
2023-05-15S, sale reported on Form 42,322$26.1K2023-05-17
2023-06-14S, sale reported on Form 42,322$24.8K2023-06-16
2023-07-14S, sale reported on Form 42,322$22.8K2023-07-18
2023-08-11S, sale reported on Form 42,322$23.2K2023-08-15
2023-09-14S, sale reported on Form 42,482$24.5K2023-09-18
2023-10-16S, sale reported on Form 42,482$22.4K2023-10-18
2023-11-14S, sale reported on Form 42,482$25.4K2023-11-16
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1820036) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms